Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir and Asunaprevir Combination in HCV Genotype 1 Null Responders
NCT01012895Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of daclatasvir, asunaprevir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Dec 2009; status: completed.
02
Drugs
daclatasvirasunaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01012895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012895.